Dr. Angelos M. Stergiou, MD, ScD h.c., one of many prominent minds behind SELLAS Life Sciences Group, is a busy pioneer innovating the neoepitope immunotherapy cancer vaccination industry. He credits his drive to succeed to his parents, stating that they are his personal heroes. In a 2016 interview,
Dr. Stergiou said: "I learned from them to accomplish my dreams – with hard work, nothing can hold you back."